Accueil > Actualité
Actualite financiere : Actualite bourse

Novartis: US, Europe accept submissions for new MS drug

( - US and European regulators have accepted Novartis' regulatory submissions for ofatumumab, a treatment of relapsing forms of multiple sclerosis, the Swiss drugmaker has said.

Both the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) have accepted the company's applications for this novel B-cell therapy, it stated.

This monoclonal antibody treatment is easy to start and manage in a monthly subcutaneous injection that can be self-administered at home using an autoinjector pen, Novartis pointed out.

Copyright (c) 2020 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.